TAB MOXAYI CVL 625 (Blue Foil)

Compositions – Amoxycillin 500mg + Clavunate 125mg + Lactic Acid Bacillus

MOXAYI CVL 625 is a combination formulation of Amoxicillin, Potassium Clavulanate, and Lactic Acid Bacillus, designed to provide effective treatment against a wide range of bacterial infections while supporting digestive health. This advanced formulation combines the antibacterial action of Amoxicillin and Clavulanate with the probiotic benefits of Lactic Acid Bacillus to help maintain healthy intestinal flora during antibiotic therapy.

Amoxicillin works by eliminating bacteria responsible for infections, while Potassium Clavulanate enhances its effectiveness by preventing bacterial resistance mechanisms. The addition of Lactic Acid Bacillus helps restore beneficial gut bacteria that may be affected during antibiotic treatment, thereby supporting digestive balance and helping reduce the risk of antibiotic-associated diarrhea.

Key Benefits

  • Effective treatment for a broad range of bacterial infections.
  • Enhanced antibacterial action against resistant bacteria.
  • Helps maintain healthy intestinal microflora.
  • Supports digestive health during antibiotic therapy.
  • May help reduce the risk of antibiotic-associated diarrhea.
  • Promotes better tolerance and overall treatment compliance.

Therapeutic Uses

MOXAYI CVL 625 Tablets are commonly prescribed for the treatment of:

Respiratory Tract Infections

  • Sinusitis
  • Tonsillitis
  • Pharyngitis
  • Bronchitis
  • Pneumonia

Ear, Nose & Throat Infections

  • Ear Infections (Otitis Media)
  • Sinus Infections
  • Throat Infections

Urinary Tract Infections (UTIs)

  • Bacterial infections affecting the urinary system.

Skin & Soft Tissue Infections

  • Skin infections
  • Wound infections
  • Soft tissue bacterial infections

Dental Infections

  • Tooth abscesses and other bacterial dental infections.

How It Works

Amoxicillin
A penicillin-class antibiotic that works by preventing bacteria from forming their protective cell walls, leading to bacterial destruction.

Potassium Clavulanate
A beta-lactamase inhibitor that protects Amoxicillin from bacterial enzymes that can cause antibiotic resistance, thereby improving its effectiveness.

Lactic Acid Bacillus
A beneficial probiotic that helps replenish healthy gut bacteria, supports digestive balance, and assists in reducing gastrointestinal disturbances associated with antibiotic use.

Composition

  • Amoxicillin IP
  • Potassium Clavulanate IP
  • Lactic Acid Bacillus
  • Equivalent to MOXAYI CVL 625

Important Information

MOXAYI CVL 625 is effective only against bacterial infections and is not intended for the treatment of viral infections such as the common cold or influenza.

MOXAYI CVL 625 Tablets provide a balanced approach to infection management by combining effective antibacterial therapy with probiotic support for improved digestive comfort and overall patient well-being.

Additional information

Packing/ Type

10×10 Alu/Alu